Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -66.99%2B | 24.71%1.81B | 163.16%21.82B | 194.99%6.04B | 127.34%2.26B | 43.32%1.45B | 105.45%8.29B | 314.15%4.23B | 101.80%2.05B | -0.22%995M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -45.65%-871M | 180.67%1.78B | -55.33%-4.19B | -133.15%-598M | 74.81%-909M | -518.37%-2.21B | -360.67%-2.7B | -36.90%-1.42B | 177.62%1.8B | -0.00%-3.61B |
| Other operating expenses | 5.39%1.12B | 32.10%1.78B | 68.84%5.21B | -46.44%1.06B | 125.56%1.5B | 1.20%1.35B | 14.27%3.09B | 52.14%868.62M | 185.45%1.98B | -0.14%665M |
| Total other operating income | 19.93%1.99B | ---- | 62.54%9.41B | 865.67%1.66B | -43.62%2.41B | 341.99%3.56B | 247.44%5.79B | 42.30%2.29B | 305.73%171.49M | -0.02%4.27B |
| Operating profit | -56.85%2.87B | -99.32%25M | 136.67%26.02B | 2,609.45%6.64B | -31.11%3.17B | 657.35%3.66B | 266.38%10.99B | 174.31%5.66B | -32.95%245.14M | -0.04%4.6B |
| Net non-operating interest income (expenses) | 750.00%13M | 125.00%4M | 57.33%-32M | 90.25%-2M | 57.14%-9M | 20.00%-16M | 13.60%-75M | 42.00%-12.5M | 14.72%-20.51M | 1.87%-21M |
| Non-operating interest income | 14.29%80M | 464.71%96M | 3,650.00%225M | 21,571.83%70M | --66M | --17M | 137.81%6M | 1,844.49%5.11M | -63.87%323K | --0 |
| Non-operating interest expense | -6.94%67M | 178.79%92M | 217.28%257M | 245.61%72M | 257.14%75M | 65.00%33M | -9.33%81M | -19.27%17.62M | -16.48%20.83M | -3.07%21M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -56.62%2.88B | -99.18%30M | 137.98%25.99B | 2,856.38%6.64B | -30.94%3.17B | 686.83%3.64B | 274.79%10.92B | 176.70%5.65B | -34.23%224.63M | -0.01%4.58B |
| Income tax | -54.06%934M | -72.97%303M | 135.55%7.88B | 2,472.64%2.03B | -31.85%950M | 678.47%1.12B | 274.98%3.35B | 183.78%1.73B | -29.75%79.02M | -0.01%1.39B |
| Net income | -57.74%1.95B | -110.83%-273M | 139.04%18.11B | 3,063.95%4.61B | -30.57%2.21B | 690.28%2.52B | 274.70%7.57B | 173.69%3.92B | -36.44%145.61M | -0.01%3.19B |
| Net income continuous operations | -57.75%1.95B | -110.82%-273M | 139.05%18.11B | 3,064.64%4.61B | -30.54%2.22B | 690.60%2.52B | 274.70%7.57B | 173.69%3.92B | -36.44%145.61M | -0.01%3.19B |
| Noncontrolling interests | -7M | 0 | 0 | |||||||
| Net income attributable to the company | -57.67%1.95B | -110.83%-273M | 139.05%18.11B | 3,063.95%4.61B | -30.57%2.21B | 690.28%2.52B | 274.70%7.57B | 173.69%3.92B | -36.44%145.61M | -0.01%3.19B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -57.67%1.95B | -110.83%-273M | 139.05%18.11B | 3,063.95%4.61B | -30.57%2.21B | 690.28%2.52B | 274.70%7.57B | 173.69%3.92B | -36.44%145.61M | -0.01%3.19B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -58.43%57.64 | -110.64%-8.0894 | 107.60%544.67 | 2,561.61%138.67 | -34.36%66.72 | 549.21%76.06 | 252.07%262.37 | 145.10%129.35 | -38.08%5.21 | -13.19%101.6414 |
| Diluted earnings per share | -57.45%55.29 | -111.38%-8.0894 | 109.34%510.65 | 2,584.92%129.95 | -38.59%62.42 | 554.30%71.1 | 256.22%243.93 | 148.04%120.45 | -38.00%4.84 | -6.46%101.6414 |
| Dividend per share | 0 | 0 | 34 | 0 | 12 | |||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |